Concepedia

Vladimir Aladinskiy

VA

22

Publications

3.4K

Citations

16

H-Index

2017

Active since

Affiliations

Moscow Institute of Physics and Technology(Current)

Insilico Medicine (United States)

Insilicos (United States)

Lomonosov Moscow State University

Institute of Biochemistry and Genetics of Ufa Scientific Centre

Vladimir Aladinskiy is an author at Moscow Institute of Physics and Technology specializing in drug discovery, medicine, and pharmacology.

Top concepts

PharmacologyMedicineDrug DiscoveryMolecular BiologyMedicinal ChemistryNatural SciencesSystems BiologyDrug DevelopmentBiomolecular EngineeringEngineering

Publications per year

2017–2024

22

Publications

22

Deep learning enables rapid identification of potent DDR1 kinase inhibitors

Alex Zhavoronkov, Yan A. Ivanenkov, Alex Aliper et al. · Nature Biotechnology · 2019 · 1.4K citations

Drug Target, Engineering, De Novo Drug Design +10

Reinforced Adversarial Neural Computer for <i>de Novo</i> Molecular Design

Evgeny Putin, Arip Asadulaev, Yan A. Ivanenkov et al. · Journal of Chemical Information and Modeling · 2018 · 374 citations · Full text

Drug Target, Engineering, Machine Learning +18

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

Feng Ren, Xiao Ding, Min Zheng et al. · Chemical Science · 2023 · 292 citations · Full text

Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery

Daniil Polykovskiy, Alexander Zhebrak, Dmitry Vetrov et al. · Molecular Pharmaceutics · 2018 · 278 citations

Engineering, Machine Learning, Autoencoders +16

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

Feng Ren, Alex Aliper, Jian Chen et al. · Nature Biotechnology · 2024 · 219 citations · Full text

Rows per page

1–5 of 22